C-6 aryl substituted 4-quinolone-3-carboxylic acids as inhibitors of hepatitis C virusCHEN, Yue-Lei; ZACHARIAS, Jeana; VINCE, Robert et al.Bioorganic & medicinal chemistry. 2012, Vol 20, Num 15, pp 4790-4800, issn 0968-0896, 11 p.Article

HCV NS5B polymerase-bound conformation of a soluble sulfonamide inhibitor by 2D transferred NOESYYANNOPOULOS, Constantin G; PING XU; PROULX, Melanie et al.Bioorganic & medicinal chemistry letters (Print). 2004, Vol 14, Num 21, pp 5333-5337, issn 0960-894X, 5 p.Article

Investigation of the mode of binding of a novel series of N-benzyl-4-heteroaryl-1-(phenylsulfonyl)piperazine-2-carboxamides to the hepatitis C virus polymeraseGENTLES, Robert G; SHERIFF, Steven; MORIN, Paul et al.Bioorganic & medicinal chemistry letters (Print). 2011, Vol 21, Num 8, pp 2212-2215, issn 0960-894X, 4 p.Article

Dual pro-drugs of 2'-C-methyl guanosine monophosphate as potent and selective inhibitors of hepatitis C virusMCGUIGAN, Christopher; MADELA, Karolina; KOLYKHALOV, Alexander et al.Bioorganic & medicinal chemistry letters (Print). 2011, Vol 21, Num 19, pp 6007-6012, issn 0960-894X, 6 p.Article

3-Hydroxyisoquinolines as inhibitors of HCV NS5b RNA-dependent RNA polymeraseHENDRICKS, Robert T; SPENCER, Stacey R; JOSEY, John A et al.Bioorganic & medicinal chemistry letters (Print). 2009, Vol 19, Num 2, pp 410-414, issn 0960-894X, 5 p.Article

HCV NS5B polymerase inhibitors 2: Synthesis and in vitro activity of (1,1-dioxo-2H-[1,2,4]benzothiadiazin-3-yl) azolo[1,5-a]pyridine and azolo[1,5-a]pyrimidine derivativesGUANGYI WANG; HUOXING LEI; BAILEY, Sarah E et al.Bioorganic & medicinal chemistry letters (Print). 2009, Vol 19, Num 15, pp 4480-4483, issn 0960-894X, 4 p.Article

HCV NS5B polymerase inhibitors 3: Synthesis and in vitro activity of 3-(1,1-dioxo-2H-[1,2,4]benzothiadiazin-3-yl)-4-hydroxy-2H-quinolizin-2-one derivativesGUANGYI WANG; LAIGUO ZHANG; SEIWERT, Scott D et al.Bioorganic & medicinal chemistry letters (Print). 2009, Vol 19, Num 15, pp 4484-4487, issn 0960-894X, 4 p.Article

Non-nucleoside inhibitors of HCV polymerase NS5B. Part 4: Structure-based design, synthesis, and biological evaluation of benzo[d]isothiazole-1,1-dioxidesDE VICENTE, Javier; HENDRICKS, Robert T; HILGENKAMP, Ramona K et al.Bioorganic & medicinal chemistry letters (Print). 2009, Vol 19, Num 19, pp 5652-5656, issn 0960-894X, 5 p.Article

Substituted benzothiadizine inhibitors of Hepatitis C virus polymeraseSHAW, Antony N; TEDESCO, Rosanna; JOHNSTON, Victor K et al.Bioorganic & medicinal chemistry letters (Print). 2009, Vol 19, Num 15, pp 4350-4353, issn 0960-894X, 4 p.Article

Discovery of tricyclic 5,6-dihydro-1H-pyridin-2-ones as novel, potent, and orally bioavailable inhibitors of HCV NS5B polymeraseRUEBSAM, Frank; MURPHY, Douglas E; BLAZEL, Julie K et al.Bioorganic & medicinal chemistry letters (Print). 2009, Vol 19, Num 22, pp 6404-6412, issn 0960-894X, 9 p.Article

Hexahydro-pyrrolo-and hexahydro-1H-pyrido[1,2-b]pyridazin-2-ones as potent inhibitors of HCV NS5B polymeraseRUEBSAM, Frank; ZHONGXIANG SUN; PATEL, Rupal et al.Bioorganic & medicinal chemistry letters (Print). 2008, Vol 18, Num 18, pp 5002-5005, issn 0960-894X, 4 p.Article

Novel HCV NS5B polymerase inhibitors derived from 4-(1',1'-dioxo-1 '4'-dihydro-1λ-benzo[1',2',4']thiadiazin-3-yl)-5-hydroxy-2H-pyridazin-3-ones: Part 4. Optimization of DMPK propertiesSERGEEVA, Maria V; YUEFEN ZHOU; PATEL, Rupal et al.Bioorganic & medicinal chemistry letters (Print). 2008, Vol 18, Num 11, pp 3421-3426, issn 0960-894X, 6 p.Article

Structure-based design, synthesis, and biological evaluation of 1,1-dioxoisothiazole and benzo[b]thiophene-1,1-dioxide derivatives as novel inhibitors of hepatitis C virus NS5B polymeraseSUN HEE KIM; TRAN, Martin T; WEBBER, Stephen E et al.Bioorganic & medicinal chemistry letters (Print). 2008, Vol 18, Num 14, pp 4181-4185, issn 0960-894X, 5 p.Article

Further studies on hepatitis C virus NS5B RNA-dependent RNA polymerase inhibitors toward improved replicon cell activities : Benzimidazole and structurally related compounds bearing the 2-morpholinophenyl moietyHIRASHIMA, Shintaro; OKA, Takahiro; ANDO, Izuru et al.Bioorganic & medicinal chemistry letters (Print). 2007, Vol 17, Num 11, pp 3181-3186, issn 0960-894X, 6 p.Article

Inhibitors of HCV NS5B polymerase : Synthesis and structure- activity relationships of N-alkyl-4-hydroxyquinolon-3-yl-benzothiadiazine sulfamidesKRUEGER, A. Chris; MADIGAN, Darold L; HONGMEI MO et al.Bioorganic & medicinal chemistry letters (Print). 2006, Vol 16, Num 13, pp 3367-3370, issn 0960-894X, 4 p.Article

Synthesis and characterization of 2'-C-Me branched C-nucleosides as HCV polymerase inhibitorsCHO, Aesop; LIJUN ZHANG; FENG, Joy Y et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 12, pp 4127-4132, issn 0960-894X, 6 p.Article

The Synthesis and evaluation of a novel class of (E)-3-(1-cyclohexyl-1H-pyrazol-3-yl)-2-methylacrylic acid Hepatitis C virus polymerase NS5B inhibitorsMARTIN, Scott W; GLUNZ, Peter; FRIDELL, Robert et al.Bioorganic & medicinal chemistry letters (Print). 2011, Vol 21, Num 10, pp 2869-2872, issn 0960-894X, 4 p.Article

Current Perspective of HCV NS5B Inhibitors: A ReviewPATIL, V. M; GUPTA, S. P; SAMANTA, S et al.Current medicinal chemistry. 2011, Vol 18, Num 36, pp 5564-5597, issn 0929-8673, 34 p.Article

Discovery of novel HCV polymerase inhibitors using pharmacophore-based virtual screeningNAM DOO KIM; CHUN, Haarin; SANG JIN PARK et al.Bioorganic & medicinal chemistry letters (Print). 2011, Vol 21, Num 11, pp 3329-3334, issn 0960-894X, 6 p.Article

The discovery and structure―activity relationships of pyrano[3,4-b]indole-based inhibitors of hepatitis C virus NS5B polymeraseJACKSON, Randy W; LAPORTE, Matthew G; BURNS, Christopher J et al.Bioorganic & medicinal chemistry letters (Print). 2011, Vol 21, Num 11, pp 3227-3231, issn 0960-894X, 5 p.Article

Non-nucleoside inhibitors of HCV polymerase NS5B. Part 2: Synthesis and structure―activity relationships of benzothiazine-substituted quinolinedionesDE VICENTE, Javier; HENDRICKS, Robert T; HILGENKAMP, Ramona K et al.Bioorganic & medicinal chemistry letters (Print). 2009, Vol 19, Num 13, pp 3642-3646, issn 0960-894X, 5 p.Article

Synthesis and biological activity of heteroaryl 3-(1,1-dioxo-2H-(1,2,4)-benzo-thiadizin-3-yl)-4-hydroxy-2(1H)-quinolinone derivatives as hepatitis C virus NS5B polymerase inhibitorsTEDESCO, Rosanna; DEPING CHAI; SHAW, Antony N et al.Bioorganic & medicinal chemistry letters (Print). 2009, Vol 19, Num 15, pp 4354-4358, issn 0960-894X, 5 p.Article

Non-nucleoside inhibitors of HCV polymerase NS5B. Part 3: Synthesis and optimization studies of benzothiazine-substituted tetramic acidsDE VICENTE, Javier; HENDRICKS, Robert T; HILGENKAMP, Ramona K et al.Bioorganic & medicinal chemistry letters (Print). 2009, Vol 19, Num 19, pp 5648-5651, issn 0960-894X, 4 p.Article

The Medicinal Chemistry of Dengue FeverSTEVENS, Andrew J; GAHAN, Michelle E; MAHALINGAM, Suresh et al.Journal of medicinal chemistry (Print). 2009, Vol 52, Num 24, pp 7911-7926, issn 0022-2623, 16 p.Article

Novel HCV NS5B polymerase inhibitors derived from 4-1',1'-dioxo-1',4'-dihydro1'λ⁶-benzo(1',1',4'] thiadiazin-3'-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 3. Further optimization of the 2-, 6-, and 7'-substituents and initial pharmacokinetic assessmentsLI, Lian-Sheng; YUEFEN ZHOU; RUEBSAM, Frank et al.Bioorganic & medicinal chemistry letters (Print). 2008, Vol 18, Num 11, pp 3446-3455, issn 0960-894X, 10 p.Article